Efficacy of hepatic resection and transarterial chemoembolization for stage B hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification

Chinese Journal of Clinical Oncology

Volumn 39, Issue 16, 2012, Pages 1225-1228

  Liu, Xing ^a   Li, Lequn ^a   Xiang, Bangde ^a   Ma, Liang ^a   Zhong, Jianhong ^a   You, Xuemei ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Hepatic resection; Hepatocellular carcinoma; Overall survival rate; Transarterial chemoembolization

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER STAGING; CHEMOEMBOLIZATION; CLINICAL EFFECTIVENESS; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; RISK FACTOR;

EID: 84869807086     PISSN: 10008179     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1000-8179.2012.16.023     Document Type: Article

References (13)

1. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma[J]. Hepatology, 2002, 35: 519-524.
2. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification[J]. Semin Liver Dis, 1999, 19: 329-338.
3. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival[J]. Hepatology, 2003, 37(2): 429-442.
4. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma[J]. Hepatology, 2002, 35(5): 1164-1171.
5. Llovet JM, Real MI, Montaña X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial[J]. Lancet, 2002, 359(9319): 1734-1739.
6. Piscaglia F, Bolondi L. The intermediate hepatocellular carcinoma stage: Should treatment be expanded[J]? Dig Liver Dis, 2010, 42 Suppl 3: S258-263.
7. Torzilli G, Donadon M, Marconi M, et al. Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis[J]. Arch Surg, 2008, 143(11): 1082-1090.
8. Lin CT, Hsu KF, Chen TW, et al. Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice[J]? World J Surg, 2010, 34(9): 2155-2161.
9. Ng KK, Vauthey JN, Pawlik TM, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database[J]. Ann Surg Oncol, 2005, 12(5):364-373.
10. Ho MC, Huang GT, Tsang YM, et al. Liver resection improves the survival of patients with multiple hepatocellular carcinomas[J]. Ann Surg Oncol, 2009, 16(4): 848-855.
11. Wang JH, Changchien CS, Hu TH, et al. The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma-Survival analysis of 3892 patients[J]. Eur J Cancer, 2008, 44(7): 1000-1006.
12. Ruzzenente A, Capra F, Pachera S, et al. Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients[J]. J Gastrointest Surg, 2009, 13(7):1313-1320.